Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib
暂无分享,去创建一个
Martin C. Müller | P. Martiat | P. Erben | A. Hochhaus | T. Schenk | A. Leitner | P. La Rosée | S. Saussele | T. Klag